MedPath

Diurex

Canadian Diurex Water Caplets

Approved
Approval ID

874aa629-1330-0c30-e053-2a95a90ac888

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 7, 2025

Manufacturers
FDA

Kobayashi Healthcare International, Inc.

DUNS: 156391729

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pamabrom

PRODUCT DETAILS

NDC Product Code52389-349
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationORAL
Effective DateMay 7, 2025
Generic NamePamabrom

INGREDIENTS (15)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POTASSIUM GLUCONATEInactive
Code: 12H3K5QKN9
Classification: IACT
RIBOFLAVINInactive
Code: TLM2976OFR
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
PAMABROMActive
Quantity: 50 mg in 1 1
Code: UA8U0KJM72
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVP
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
CALCIUM SULFATE DIHYDRATEInactive
Code: 4846Q921YM
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diurex - FDA Drug Approval Details